This ERN RARE-LIVER Webinar was held on 18 March 2025 in collaboration with the VALDIG group.
New guidelines on vascular liver diseases has just been published by VALDIG.
This webinar aims to summarise the main issues and focus on some highly specialised points-of-interest.
Chairs |
|
 |
Pierre Deltenre is a Specialist in Hepatology. He completed his medical training in the University of Louvain in Belgium in 1997. He undertook a research fellowship in Professor Valla’s unit at Beaujon Hospital in Clichy in France between 1996 and 1997. Between 1999 and 2013, he was consultant in CHRU of Lille, France in the team of Professor Mathurin. He achieved his Ph.D. in Erasme Hospital (Free University of Brussels, Belgium) in 2012. He worked in Lausanne University Hospital between 2013 and 2017. He is now working in the unit of Hepato-Gastroenterology in Clinique Saint-Luc, Namur, and in the Department of Hepatology and Gastroenterology of Erasme University Hospital, Brussels, Belgium. Pierre Deltenre is “Maître de Conférence” at Free University of Brussels, Belgium. His main research interests are complications of cirrhosis and vascular liver diseases. |
 |
Laure Elkrief, MD, PhD, is hepatologist in the liver unit of Tours University Hospitals, France. She was trained in the Liver unit at Hôpital Beaujon from 2010 to 2014. She worked in the Hepato-gastroenterology and Transplant Unit of Geneva University Hospitals from 2014 to 2019. Laure Elkrief is a clinical expert in portal hypertension, complications of cirrhosis, vascular liver disorders, and liver transplantation. Her clinical research interests include the use of non-invasive tests for the diagnosis and prognosis of liver diseases, and the role of comorbidities in patients with liver diseases. Laure Elkrief is currently the vice secretary of VALDIG. |
 |
Dr. Virginia Hernandez-Gea is a physician-scientist specializing in the management of portal hypertension (PH) in cirrhosis and vascular liver diseases (VLD). She works at the hemodynamic unit at Hospital Clinic in Barcelona, an internationally recognized center for VLD management, where she performs liver catheterizations, TIPS placements, and manages patients with PH both due to cirrhosis and VLD. Dr. Hernandez-Gea conducts both clinical and translational research. She currently serves as Chair of VALDIG and has previously been a member of the EASL Scientific Committee, contributing to the development of EASL Clinical Practice Guidelines on vascular liver diseases. |
Speakers |
|
 |
Walter Ageno is a Professor of Medicine at the University of Insubria in Varese, Italy and Head of the Department of Medicine at the teaching hospital of Bellinzona, Switzerland. He is former Director of the Emergency Medicine Unit and the Thrombosis Center of the Ospedale di Circolo of Varese, Italy. He has authored more than 700 articles indexed in MEDLINE in the field of venous and arterial thrombosis. Dr. Ageno was chairman of the Italian Society of Hemostasis and Thrombosis and of the Scientific Subcommittee Board of the International Society on Thrombosis and Haemostasis. He is associate editor for the Journal of Thrombosis and Haemostasis and Internal and Emergency Medicine. |
 |
Pierre-Emmanuel Rautou (MD, PhD) is a clinical specialist in Hepatology with a PhD in vascular biology (2011). He is Professor of Hepatology at Université Paris-Cité and Hôpital Beaujon (Clichy, France) since 2016. He is the head of the splanchnic hemodynamic laboratory at Beaujon Hospital (Clichy, France) since 2012. He is also leading an Inserm team dedicated to the study of the role of vessels in liver diseases, at the INSERM Unit 1149 (Paris Research Center on Inflammation). His research is focused on the role of vessels in liver diseases. Specifically, he is interested in primary vascular liver diseases (portal vein thrombosis and porto-sinusoidal vascular disorder), as well as in vascular involvement in common liver diseases development and complications (extracellular vesicules, coagulation, endothelial cells). |
Log in to post comments